维普中文期刊产品整合服务
75篇 您的检索式:作者名="PETRIOLI"
    题名 作者 年代 出处 被引量
1Gastric cancer: Current status of lymph node dissection显示文摘D2 procedure has been accepted in Far East as the standard treatment for both early(EGC) and advanced gastric cancer(AGC) for many decades. Recently EGC has been successfully treated with endoscopy by endoscopic mucosal resection or endoscopic submucosal dissection, when restricted or extended Gotoda's criteria can be applied and D1+ surgery is offered only to patients not fitted for less invasive treatment. Furthermore, two randomised controlled trials(RCTs) have been demonstrating the non inferiority of minimally invasive technique as compared to standard open surgery for the treatment of early cases and recently the feasibility of adequate D1+ dissection has been demonstrated also for the robot assisted technique. In case of AGC the debate on the extent of nodal dissection has been open for many decades. While D2 gastrectomy was performed as the standard procedure in eastern countries, mostly based on observational and retrospective studies, in the west the Medical Research Council(MRC), Dutch and Italian RCTs have been conducted to show a survival benefit of D2 over D1 with evidence based medicine. Unfortunately both the MRC and the Dutch trials failed to show a survival benefit after the D2 procedure, mostly due to the significant increase of postoperative morbidity and mortality, which was referred to splenopancreatectomy. Only 15 years after the conclusion of its accrual, the Dutch trial could report a significant decrease of recur-rence after D2 procedure. Recently the long term survival analysis of the Italian RCT could demonstrate a benefit for patients with positive nodes treated with D2 gastrectomy without splenopancreatectomy. As nowadays also in western countries D2 procedure can be done safely with pancreas preserving technique and without preventive splenectomy, it has been suggested in several national guidelines as the recommended procedure for patients with AGC.Maurizio Degiuli Giovanni De Manzoni Alberto Di Leo Domenico D'Ugo Erica Galasso Daniele Marrelli Roberto Petrioli Karol Polom Franco Roviello Francesco Santullo Mario Morino 2016World Journal of Gastroenterology2016,22,10:29
2CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab显示文摘Roberto Petrioli Antonella Licchetta Giandomenico Roviello Alessandra Pascucci Edoardo Francini Gianluca Bargagli Raffaele Conca Salvatora Tindara Miano Giuseppe Marzocca Guido Francini Multidisciplinary Oncology Group on Gastrointestinal Tumors 2012Cancer Investigation2012,,1:2
3Carboplatin, methotrex- ate, vinblastine, and epirubicin (M - VECa) as salvage treatment in patients with advanced bladder cancer: a phase I] study显示文摘Petrioli R Roviello G Fiaschi AI 2015Anticancer Drugs2015,26,8:1
4Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids显示文摘FRANCINI G PETRIOLI R MONTAGNANI A 2006Br J Cancer2006,17,2:1
5Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer:a randomised phase Ⅱ study显示文摘Petrioli R Pascucci A Conca R 2011Br J Cancer2011,104,4:1
6Weekly docetaxel and epirubicin in treatment of advanced honneone-refractory prostate cancer显示文摘Petrioli R Paolelli L Franeini E 2007Urology2007,69,1:1
7Localized protocolsfor ad hoe clustering and backbone formation: a performance comparison 显示文摘Basagni A P S Mastrogiovanni M Petrioli C 2006IEEE Transactions on Parallel and Distributed Systems2006,17,4:1
8Configuring bluestars: Multihop scatternet formation for Bluetooth networks显示文摘PETRIOLI C BASAGNI S CHLAMTAC I 2003IEEE Transactions on Computers2003,52,6:1
9Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer显示文摘Petrioli R Paolelli L Francini E 2007Urology2007,69,1:1
10Anti-eollision protocols for single reader RFID systems: tempo- ral analysis and optimization显示文摘Porta TFL Maselli G Petrioli C 2011IEEE Trans Mobile Comput2011,10,:1
11BlueMesh: Degree-Constrained Multi-Hop Scatternet Formation for Bluetooth Networks显示文摘PETRIOLI C BASAGNI S CHLAMTAC I 2004Mobile Networks and Applications2004,9,1:1
12Weekly low-dose docetaxel in advanced non-small cell lung cancer previously trea-ted with two chemotherapy regimens显示文摘Petrioli R Pozzessere D Messinese S 2003Lung Cancer2003,39,1:1
13Degree-constrained multihop scatternet formation for Bluetooth networks显示文摘 Basagni S 2004Mobile Networks and Application2004,9,1:1
14The role of doxorubicin and epimbiein in the treatment of patients with metastatic hormonerefract- ory prostate cancer显示文摘Petrioli R Fiaschi A Francini E 2008Cancer Treat Rev2008,34,:1
15Sequential treatment with epirubi- cin, oxaliplatin and 5 FU (EOF) followed by docetaxel, oxaliplatin and 5FU(DOF) in patients with advanced gastric or gastroesophageal cancer: a single - institution experience 显示文摘Petrioli R Francini E Roviello F 2015Cancer Chemother Phar- maco12015,75,5:1
16Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin显示文摘Petrioli R Bargagli G Lazzi S 2010Anticancer Drugs2010,21,3:1
17Weekly high - dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel 显示文摘Petrioli R Pascucci A Francini E 2007BJU Int2007,100,4:1
18Anti-collision protocols for single-reader RFID systems: Temporal analysis and optimization 显示文摘Porta L T Maselli G Petrioli C 2010IEEE Trans on Mobile Computing2010,10,2:1
19Degree-constrained multihop scatternet formation for bluetooth networks显示文摘Chiara Petrioli Stefano Basagni 2004Mobile Networks and Applications2004,9,:1
20Configuring BlueStars :Multihop Scatternet Formation for Bluetooth Networks 显示文摘PETRIOLI C 2003IEEE Transactions on Computers2003,,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费